Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences. [electronic resource]
- Annals of the rheumatic diseases Nov 2000
- i85-9 p. digital
Publication Type: Journal Article; Review
0003-4967
10.1136/ard.59.suppl_1.i85 doi
Antibodies, Monoclonal--therapeutic use Antirheumatic Agents--therapeutic use Humans Spondylitis--therapy Tumor Necrosis Factor-alpha--antagonists & inhibitors